drugset / Trial / NCT04322968

Ketamine Infusion for Comorbid PTSD and Chronic Pain

NCT04322968

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to investigate the effectiveness of low dose IV ketamine infusion in the treatment of patients with PTSD and comorbid chronic pain. Hypothesis: A single ketamine infusion should be associated with significantly greater reduction in core PTSD symptom levels after the treatment and such an effect is not only due to its analgesic properties but also through unknown mechanism of action that maybe related to NMDA/AMPA receptor modulation.

Timeline

Start
2018-01-09
Primary completion
2019-06-04
Completion
2019-06-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg
Subject Ketorolac Other / unclassified 15 mg